Opendata, web and dolomites

EMPAtHy SIGNED

Endothelial Cell Molecular and Metabolic Heterogeneity in Pulmonary Arterial Hypertension

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EMPAtHy project word cloud

Explore the words cloud of the EMPAtHy project. It provides you a very rough idea of what is the project "EMPAtHy" about.

innovative    ph    sequencing    academia    successful    never    rna    science    heterogeneous    paradigm    phenotypically    phenotypic    gene    exposed    basis    devastating    metabolism    endothelial    replacement    stimuli    lung    output    scrna    curative    driving    achievement    scientific    rewiring    patients    forces    dramatic    me    shown    overlooked    international    time    expertise    hemodynamic    remodeling    background    pathophysiology    ameliorative    heterogeneity    though    single    pah    arterial    yield    poor    cells    combining    incurable    model    foundation    disciplinary    vivo    survival    experimental    microenvironments    diverse    exception    metabolically    frontline    hypertension    promises    expression    metabolic    proof    environment    cell    therapy    competitive    isolated    ecs    arteries    ec    intense    career    small    pressure    phd    profiles    intrapulmonary    1st    clinically    promotes    subpopulations    animal    pulmonary    host    validated    unbiased    lab    insights    disease    seq    goals    lay    thesis    vascular    freshly   

Project "EMPAtHy" data sheet

The following table provides information about the project.

Coordinator
VIB VZW 

Organization address
address: RIJVISSCHESTRAAT 120
city: ZWIJNAARDE - GENT
postcode: 9052
website: www.vib.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 166˙320 €
 EC max contribution 166˙320 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2021-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIB VZW BE (ZWIJNAARDE - GENT) coordinator 166˙320.00

Map

 Project objective

BACKGROUND: Pulmonary arterial hypertension (PAH) is a devastating disease, characterized by a dramatic increase in pulmonary arterial pressure and an intense remodeling of small intrapulmonary arteries. With the exception of the lung replacement therapy, PAH remains an incurable disease with poor survival. Recent studies have shown that in PAH, rewiring of the metabolism of the lung endothelial cells (ECs) promotes vascular remodeling. However, these studies overlooked that lung ECs are exposed to diverse microenvironments in vivo (various hemodynamic forces and stimuli), which might result in their phenotypic and metabolic heterogeneity, though this has never been investigated. OBJECTIVES & EXPERIMENTAL APPROACH: In order to characterize, for the 1st time, the lung EC heterogeneity in PAH, identify EC subsets, and determine in an unbiased way the metabolic gene expression profiles of these EC subsets, I will use single-cell RNA-sequencing (scRNA-seq) on freshly isolated lung ECs from PAH patients and from an animal model of PH. As proof-of-concept, I will evaluate the effects of a new metabolic therapy on these EC subsets, in vivo, in comparison to a clinically-used, ameliorative but not curative, PAH therapy. This approach, already validated in the host lab, promises to lay the foundation of a new paradigm in PAH where lung ECs are phenotypically and metabolically heterogeneous. It will yield novel insights into PAH pathophysiology, identify specific EC subpopulations driving the vascular remodeling process as well as new potential metabolic targets. CAREER DEVELOPMENT: Combining my expertise on PAH (PhD thesis) together with state-of-the-art frontline technology (scRNA-seq) and innovative science (EC metabolism) (within the host lab) in a multi-disciplinary project and international research environment will ensure successful achievement of the project goals, enhance my scientific output and offer me a highly competitive basis for my future career in academia.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EMPATHY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EMPATHY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

NSTree (2020)

Understanding substrate delivery for cell wall biosynthesis in plants

Read More  

BB-SLM (2020)

Polychromatic digital optics for structured light

Read More  

MetEpiC (2020)

P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis

Read More